Serotonin (2C) receptor regulation of cocaine-induced conditioned place preference and locomotor sensitization

Behavioural Brain Research

Volumn 238, Issue 1, 2013, Pages 206-210

  Craige, Caryne P ^a   Unterwald, Ellen M ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

5 HT2C receptor; Cocaine; Hyperactivity; Reward; Sensitization

Indexed keywords

2 (6 CHLORO 5 FLUORO 1 INDOLYL) 1 METHYLETHYLAMINE; COCAINE; SEROTONIN 2C RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DRUG EFFECT; HYPERACTIVITY; LOCOMOTION; MALE; MOUSE; NERVE STIMULATION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; REWARD; SENSITIZATION;

ANIMALS; ASSOCIATION LEARNING; BEHAVIOR, ANIMAL; COCAINE; CONDITIONING (PSYCHOLOGY); DOPAMINE UPTAKE INHIBITORS; ETHYLAMINES; INDOLES; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN 5-HT2 RECEPTOR AGONISTS;

EID: 84868682042     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.10.034     Document Type: Article

References (32)

1. Calligaro D.O., Eldefrawi M.E. High affinity stereospecific binding of [3H] cocaine in striatum and its relationship to the dopamine transporter. Molecular Membrane Biology 1987, 7(2):87-106.
2. Czoty P.W., Justice J.B., Howell L.L. Cocaine-induced changes in extracellular dopamine determined by microdialysis in awake squirrel monkeys. Psychopharmacology 2000, 148(3):299-306.
3. Heikkila R.E., Orlansky H., Cohen G. Studies on the distinction between uptake inhibition and release of [3H] dopamine in rat brain tissue slices. Biochemical Pharmacology 1975, 24(8):847-852.
4. Nicolaysen L.C., Justice J.B. Effects of cocaine on release and uptake of dopamine in vivo: differentiation by mathematical modeling. Pharmacology Biochemistry and Behavior 1988, 31(2):327-335.
5. Ritz M.C., Lamb R.J., Goldberg, Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987, 237(4819):1219-1223.
6. Koe B.K. Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. Journal of Pharmacology and Experimental Therapeutics 1976, 199(3):649-661.
7. Reith M.E., Sershen H., Allen D.L., Lajtha A. A portion of [3H] cocaine binding in brain is associated with serotonergic neurons. Molecular Pharmacology 1983, 23(3):600-606.
8. Reith M.E.A., Meisler B.E., Sershen H., Lajtha A. Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochemical Pharmacology 1986, 35(7):1123-1129.
9. Ritz M.C., Cone E.J., Kuhar M.J. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sciences 1990, 46(9):635-645.
10. Ross S.B., Renyi A.L. Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. European Journal of Pharmacology 1969, 7(3):270-277.
11. Taylor D., Ho B. Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine. Research Communications in Chemical Pathology and Pharmacology 1978, 21(1):67-75.
12. Teneud L.M., Baptista T., Murzi E., Hoebel B.G., Hernandez L. Systemic and local cocaine increase extracellular serotonin in the nucleus accumbens. Pharmacology Biochemistry and Behavior 1996, 53(3):747-752.
13. Alex K.D., Pehek E.A. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacology and Therapeutics 2007, 113(2):296-320.
14. Berg K.A., Clarke W.P., Cunningham K.A., Spampinato U. Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications. Neuropharmacology 2008, 55(6):969-976.
15. Bubar M.J., Cunningham K.A. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse. Progress in Brain Research (Elsevier) 2008, 172:319-346.
16. De Deurwaerdare P., Navailles S., Berg K.A., Clarke W.P., Spampinato U. Constitutive activity of the serotonin2C Receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. The Journal of Neuroscience 2004, 24(13):3235-3241.
17. Di Matteo V., Di Giovanni G., Di Mascio M., Esposito E. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system. Neuropharmacology 1999, 38(8):1195-1205.
18. Huang M., Dai J., Meltzer H.Y. 5-HT2A and 5-HT2C receptor stimulation are differentially involved in the cortical dopamine efflux - studied in 5-HT2A and 5-HT2C genetic mutant mice. European Journal of Pharmacology 2011, 652(1-3):40-45.
19. Navailles S., Moison D., Cunningham K.A., Spampinato U. Differential regulation of the mesoaccumbens dopamine circuit by serotonin2C receptors in the ventral tegmental area and the nucleus accumbens: an in vivo microdialysis study with cocaine. Neuropsychopharmacology 2007, 33(2):237-246.
20. Di Matteo V., Di Giovanni G., Di Mascio M., Esposito E. Biochemical and electrophysiological evidence that RO 60-0175 inhibits mesolimbic dopaminergic function through serotonin2C receptors. Brain Research 2000, 865(1):85-90.
21. Liu S., Cunningham K.A. Serotonin2C receptors (5-HT2CR) control expression of cocaine-induced conditioned hyperactivity. Drug and Alcohol Dependence 2006, 81(3):275-282.
22. Pentkowski N.S., Duke F.D., Weber S.M., Pockros L.A., Teer A.P., Hamilton E.C., et al. Stimulation of medial prefrontal cortex serotonin2C (5-HT2C) receptors attenuates cocaine-seeking behavior. Neuropsychopharmacology 2010, 35(10):2037-2048.
23. Boothman L., Raley J., Denk F., Hirani E., Sharp T. In vivo evidence that 5-HT2C receptors inhibit 5-HT neuronal activity via a GABAergic mechanism. British Journal of Pharmacology 2006, 149(7):861-869.
24. Navailles S., Moison D., Ryczko D., Spampinato U. Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors. Journal of Neurochemistry 2006, 99(4):1311-1319.
25. Neisewander J.L., Acosta J.I. Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats. Behavioural Pharmacology 2007, 18(8):791-800.
26. Everitt B., Wolf M. Psychomotor stimulant addiction: a neuronal systems perspective. Journal of Neuroscience 2002, 22:3312-3320.
27. Post R., Rose H. Increasing effects of repetitive cocaine administration in the rat. Nature 1976, 260:731-732.
28. Li Y., Hu X., Berney T., Vartanian A., Stine C., Wolf M., et al. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse 1999, 34(3):169-180.
29. Liu K., Steketee J.D. Repeated exposure to cocaine alters medial prefrontal cortex dopamine D2-like receptor modulation of glutamate and dopamine neurotransmission within the mesocorticolimbic system. Journal of Neurochemistry 2011, 119(2):332-341.
30. Di Matteo V., De Blasi A., Di Giulio C., Esposito E. Role of 5-HT2C receptors in the control of central dopamine function. Trends in Pharmacological Sciences 2001, 22(5):229-232.
31. Serrats J., Mengod G., Cortés R. Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei. Journal of Chemical Neuroanatomy 2005, 29(2):83-91.
32. Quérée P., Peters S., Sharp T. Further pharmacological characterization of 5-HT2C receptor agonist-induced inhibition of 5-HT neuronal activity in the dorsal raphe nucleus in vivo. British Journal of Pharmacology 2009, 158(6):1477-1485.